Brief: Harpoon Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update
May 11 (Reuters) - Harpoon Therapeutics Inc HARP.O :
* HARPOON THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.31
* Q1 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA
* $25 MILLION PREFERRED EQUITY FINANCING CLOSED IN MARCH
2023,
EXTENDING CASH RUNWAY INTO SECOND HALF OF 2024
Source text for Eikon: ID:nGNX8NzqDs
Further company coverage: HARP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals